Get the Stockscreener App
0.00
100.00%
-5.95
After Hours:
5.89
5.89
+
Predictive Oncology Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
See More
Previous Close:
$5.95
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$20.19M
Revenue:
$1.52M
Net Income/Loss:
$-13.97M
P/E Ratio:
0.00
EPS:
-3.05
Net Cash Flow:
$-13.29M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$39.00
Predictive Oncology Inc Stock (POAI) Company Profile
Name
Predictive Oncology Inc
Sector
Industry
Phone
412-432-1500
Address
91 43RD STREET, PITTSBURGH, MN
Compare POAI vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
POAI
Predictive Oncology Inc
|
0.00 | 20.19M | 1.52M | -13.97M | -13.29M | -3.05 |
|
VEEV
Veeva Systems Inc
|
178.88 | 29.40B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
49.98 | 8.94B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.31 | 7.36B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
77.81 | 6.65B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.16 | 4.63B | 1.10B | 112.09M | 283.19M | 0.6096 |
Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Initiated | H.C. Wainwright | Buy |
Predictive Oncology Inc Stock (POAI) Latest News
Head to Head Comparison: Predictive Oncology (AGPU) vs. Its Rivals - Defense World
FOMO Trade: Is Predictive Oncology Inc attractive for institutional investors2026 Opening Moves & Weekly Stock Breakout Alerts - baoquankhu1.vn
Predictive Oncology (NASDAQ:POAI) Shares Pass Below 200 Day Moving Average – What’s Next? - Defense World
Axe Compute Inc. Appoints Dr. Theodore Zhu and Thorston Dirks to Board of Directors – Official 8-K SEC Filing March 2026 - Minichart
Analyzing Predictive Oncology (AGPU) & Its Competitors - Defense World
Head to Head Comparison: Predictive Oncology (AGPU) versus Its Rivals - Defense World
Why analysts upgrade Predictive Oncology Inc. stockMarket Sentiment Summary & Daily Entry Point Trade Alerts - Naître et grandir
Market Rankings: Will Predictive Oncology Inc benefit from geopolitical trendsPortfolio Risk Summary & Capital Efficient Trade Techniques - baoquankhu1.vn
Comparing Predictive Oncology (AGPU) and The Competition - Defense World
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
POAI Earnings History & Surprises | EPS & Revenue Results | PREDICTIVE ONCOLOGY INC (NASDAQ:POAI) - ChartMill
POAI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Predictive Oncology Faces Challenges Compared to Rivals - National Today
Predictive Oncology (NASDAQ:POAI) Shares Cross Below 200 Day Moving Average – Time to Sell? - Defense World
Predictive Oncology (AGPU) & Its Peers Critical Review - Defense World
ReShape Lifesciences (OTCMKTS:RSLSD) and Predictive Oncology (NASDAQ:AGPU) Head-To-Head Contrast - Defense World
Comparing Predictive Oncology (AGPU) and Its Peers - Defense World
Returns Recap: Can SENEB weather a recession2025 Geopolitical Influence & High Return Trade Opportunity Guides - baoquankhu1.vn
Axe Compute explores sale of Helomics biobank business - Investing.com
Owner of 150,000 tumor samples weighs what to do with its biobank - Stock Titan
Medline (NASDAQ:MDLN) vs. Predictive Oncology (NASDAQ:AGPU) Head to Head Review - Defense World
Is Predictive Oncology Inc. (S1K) stock ideal for retirement investorsMarket Performance Report & Low Drawdown Investment Ideas - mfd.ru
Can Predictive Oncology Inc. expand into new marketsWeekly Stock Report & Risk Controlled Daily Plans - mfd.ru
Predictive Oncology (AGPU) and Its Competitors Critical Comparison - Defense World
Predictive Oncology Faces Challenges Compared to Peers - National Today
Predictive Oncology (AGPU) & Its Rivals Head to Head Contrast - Defense World
Contrasting Predictive Oncology (NASDAQ:AGPU) and Longevity Health (NASDAQ:XAGE) - Defense World
Predictive Oncology (AGPU) and Its Competitors Financial Contrast - Defense World
How Predictive Oncology Inc. stock reacts to global recession fearsEarnings Recap Report & Growth Focused Stock Reports - mfd.ru
Head-To-Head Survey: Predictive Oncology (AGPU) & The Competition - Defense World
Predictive Oncology (AGPU) and Its Peers Head to Head Analysis - Defense World
Analyzing Predictive Oncology (AGPU) and Its Competitors - Defense World
Why Predictive Oncology Inc. stock is a value investor pick2025 Biggest Moves & Technical Entry and Exit Tips - mfd.ru
Published on: 2026-02-15 02:02:07 - baoquankhu1.vn
Why Predictive Oncology Inc. stock attracts global investors2025 Major Catalysts & Verified Momentum Watchlists - mfd.ru
Is Predictive Oncology Inc. forming higher highs and higher lowsWeekly Investment Report & Entry Point Confirmation Alerts - mfd.ru
What are Predictive Oncology Inc.’s earnings expectations2025 Key Highlights & Smart Swing Trading Techniques - mfd.ru
Analyzing Predictive Oncology (NASDAQ:AGPU) & Longevity Health (NASDAQ:XAGE) - Defense World
Axe Compute appoints Christopher Miglino as chief executive officer, ushering in a new era of decentralized compute - marketscreener.com
Axe Compute names Christopher Miglino as new CEO By Investing.com - Investing.com India
Axe Compute names Christopher Miglino as new CEO - Investing.com
Axe Compute board voted to terminate CEO Raymond F. Vennnare - marketscreener.com
Axe Compute Appoints Christopher Miglino as Chief Executive Officer, Ushering in a New Era of Decentralized Compute - marketscreener.com
Christopher Miglino to lead Axe Compute (NASDAQ: AGPU) as new CEO - Stock Titan
New Axe Compute CEO to steer decentralized AI infrastructure push - Stock Titan
Predictive Oncology and Mitesco Compared in Critical Survey - National Today
MSP Recovery (NASDAQ:MSPR) & Predictive Oncology (NASDAQ:POAI) Critical Review - Defense World
Will Predictive Oncology Inc. benefit from green energy policies2025 Bull vs Bear & Weekly Momentum Stock Picks - mfd.ru
Will Predictive Oncology Inc benefit from rising consumer demandJuly 2025 Volume & Weekly High Momentum Picks - baoquankhu1.vn
Bull Bear: Is Predictive Oncology Inc a speculative investment2025 EndofYear Setup & Entry Point Confirmation Signals - baoquankhu1.vn
Jobs Data: Does NexPoint Diversified Real Estate Trust meet Warren Buffetts criteriaJuly 2025 Fed Impact & Long-Term Safe Investment Plans - baoquankhu1.vn
Predictive Oncology Inc Stock (POAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
1.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):